FEDERAL COURT OF AUSTRALIA
Novartis Pharmaceuticals Australia Pty Ltd v Bayer Australia Ltd [2015] FCA 35
Keep reading for free
Create a free CaseChat account to read Novartis Pharmaceuticals Australia Pty Ltd v Bayer Australia... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2015] FCA 35
- Decision Date
CaseChat Overview and Summary
The court was required to determine whether the respondent's conduct conveyed the pleaded representations, whether those representations were misleading or deceptive or likely to mislead or deceive, and whether the applicant's loss of sales was caused by the respondent's representations. The court also had to assess the extent of any loss, and the relevance of the dominant message conveyed by the respondent's promotional campaign.
The court found that the respondent's conduct conveyed the pleaded representations and was misleading or deceptive. The court rejected the argument that the dominant message of the promotional campaign was not misleading, as the court found that the representations made by the respondent were likely to mislead or deceive. The court held that the applicant's loss of sales was caused by the respondent's representations, and damages should be calculated as per Mr Moore’s scenario 2 using the historical loss figure but with future loss limited to the end of December 2013. The court did not include a sum for pre-judgment interest. The court ordered the parties to identify which parts of the reasons should not be published due to confidentiality, and to agree on the figure to be included in a particular paragraph of the reasons. The matter was stood over for four weeks to allow the parties to do this and to file submissions regarding costs. The proceedings were listed for the making of final orders.
Orders
Orders of the court
1. On or before 20 February 2015, the parties are to identify which parts of the reasons they contend should not be published because of confidentiality and file a proposed form of orders.
2. The parties are to endeavour to agree the figure to be included in [366] of these reasons.
3. If the applicant wishes to contend that costs should not follow the event, it should file and serve by 20 February 2015 a written submission of no more than three pages in support of that contention. If the applicant files such a written submission, the respondent is to file and serve by 28 February 2015 its written submission of no more than three pages in response.
4. The proceedings be listed at 9.30 am on 6 March 2015 for the making of orders.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi